Evaluation of hemocompatibility is an important issue in the overall assessment of the safety of nanomedicines, since the administered nanoscale materials enter the bloodstream and interact with blood plasma proteins, erythrocytes, leukocytes, platelets, and endothelial cells
Brown JM, Ball JG, Hogsett A, et al
dependence on China extends beyond core drug ingredients, also known as active pharmaceutical ingredients (APIs), and is growing toward finished-dosed generic drugs as well
These findings highlight the diverse strategies employed to overcome MDR pathogens, underscoring the importance of combining natural and synthetic antibiotic potentiators in the fight against antimicrobial resistance
e116, doi: He, Y
Driving the model to its limit: profile likelihood based model reduction